Found: 8
Select item for more details and to access through your institution.
Role of dendritic cell metabolic reprogramming in tumor immune evasion.
- Published in:
- International Immunology, 2020, v. 32, n. 7, p. 485, doi. 10.1093/intimm/dxaa036
- By:
- Publication type:
- Article
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 19, p. 19394, doi. 10.1002/cam4.6532
- By:
- Publication type:
- Article
Advances in Immunotherapy for Pancreatic Cancer: 2013.
- Published in:
- JOP Journal of the Pancreas, 2013, v. 14, n. 4, p. 347
- By:
- Publication type:
- Article
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adi4191
- By:
- Publication type:
- Article
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 672, p. 1, doi. 10.1126/scitranslmed.abq7019
- By:
- Publication type:
- Article
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4753, doi. 10.3390/cancers13194753
- By:
- Publication type:
- Article
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02876
- By:
- Publication type:
- Article